Developing as a significant development in the fight against obesity, this medication is capturing considerable interest . It combines the action of two known GLP-1 receptor agonists, dulaglutide , and an unique glucose-dependent hormonal component. Preliminary study results have indicated impressive weight loss in patients with obesity , potentia